Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 19;59(6):e02973-20.
doi: 10.1128/JCM.02973-20. Print 2021 May 19.

Four-Hour Immunochromatographic Detection of Intestinal Carriage of Carbapenemase-Producing Enterobacteriaceae: a Validation Study

Affiliations

Four-Hour Immunochromatographic Detection of Intestinal Carriage of Carbapenemase-Producing Enterobacteriaceae: a Validation Study

Salah Gallah et al. J Clin Microbiol. .

Abstract

The increasing incidence of carbapenemase-producing Gram-negative bacilli (C-PGNB) represents a major public health challenge. Rapid detection of digestive colonization with C-PGNB is fundamental to control their spread. We performed the validation of a rapid protocol for C-PGNB detection directly on rectal swabs. We developed a protocol combining enrichment by a rapid selective subculture of the rectal swab medium and realization of a Resist-4 O.K.N.V. K-SeT test on the bacterial pellet obtained. The limit of detection and performances of this protocol were validated in vitro on 52 C-PGNB strains spiked on a calibrated sample suspension and confirmed in clinical settings on 144 rectal swabs sampled from patients with C-PGNB digestive colonization (n = 48) and controls (patients with extended-spectrum beta-lactamase [ESBL] colonization [n = 48] and without carbapenemase/ESBL [n = 48]). The protocol detected, with 100% sensitivity, the presence of the 15 OXA-48-, 14 KPC-, 13 NDM-, and 10 VIM-producing GNB from 103 CFU/ml. The limit of detection was 2 × 102 CFU/ml. Among the 48 C-PGNB-containing rectal swabs of the validation cohort, 46 were accurately detected. False negative were observed for 1 NDM-producing Acinetobacter baumannii strain and 1 OXA-48-producing Escherichia coli strain. The 96 control swabs were negative. Sensitivity and specificity for C-PGNB detection were 97.7% (95% confidence interval [CI], 87.7 to 100) and 100% (95% CI, 96.2 to 100). The negative likelihood ratio was 0.04 (95% CI, 0.01 to 0.16). Considering a C-PGNB digestive colonization prevalence between 0.01% and 0.1%, positive and negative predictive values were 100%. Our protocol is a rapid and low-cost method detecting accurately the digestive colonization with carbapenemase-producing Enterobacteriaceae in 4 h without any requirement for specific equipment.

Keywords: Resist-4 O.K.N.V. K-SeT; carbapenemase; digestive colonization; extended drug resistance; rapid diagnostic test.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Determination of the limit of detection of the technique. Four representative strains, each producing one carbapenemase enzyme (E. coli OXA-48 like, circles; K. pneumoniae KPC, triangles; E. coli NDM, squares; K. pneumoniae VIM, diamonds), were assayed independently once a day for 7 days to assess between-day variations (A) and 5 times on the same day to assess within-day variations (B) at 2 final concentrations in rectal swab medium (102 and 103 CFU/ml). These experiments provided 96 results, summarized for each strain/enzyme and for all strains/enzymes in panel C. Solid symbols represent positive tests; empty symbols represent negative tests. Gray symbols in panel B represent the median value of the inoculum of the 5 replicates of within-day experiments. Dotted lines in panels A, B, and C represent the limit of detection of the technique set around 2 × 102 CFU/ml.

References

    1. Koulenti D, Song A, Ellingboe A, Abdul-Aziz MH, Harris P, Gavey E, Lipman J. 2019. Infections by multidrug-resistant Gram-negative bacteria: what’s new in our arsenal and what’s in the pipeline? Int J Antimicrob Agents 53:211–224. doi:10.1016/j.ijantimicag.2018.10.011. - DOI - PubMed
    1. European Center for Disease Control. 2018. European country overview of antimicrobial consumption 2018. European Center for Disease Control, Solna, Sweden.
    1. Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL. 2015. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries. Euro Surveill doi:10.2807/1560-7917.ES.2015.20.45.30062. - DOI - PubMed
    1. Nordmann P. 2014. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect 44:51–56. doi:10.1016/j.medmal.2013.11.007. - DOI - PubMed
    1. Peri AM, Doi Y, Potoski BA, Harris PNA, Paterson DL, Righi E. 2019. Antimicrobial treatment challenges in the era of carbapenem resistance. Diagn Microbiol Infect Dis 94:413–425. doi:10.1016/j.diagmicrobio.2019.01.020. - DOI - PubMed

LinkOut - more resources